Genitourinary Syndrome of Menopause: A Clinician’s Guide to Screening, Diagnosis, and Treatment
Launch Date: 1/27/2020
Expiration Date: 1/27/2023
This one-hour, recorded webinar for clinicians will cover epidemiology, etiology, screening, diagnosis, and treatment of genitourinary symptoms of menopause (GSM).
At the conclusion of this activity, participants should be able to:
- Describe the symptoms of genitourinary symptoms of menopause (GSM), with a focus on vulvovaginal atrophy
- Summarize the process for GSM screening and diagnosis
- List and describe GSM treatment options
- Explain effective techniques for patient communication around GSM, including cultural considerations
- Apply what they have learned to two clinical case studies
In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and American Sexual Health Association. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Indiana University School of Medicine designates this activity for a maximum of 1.25 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Indiana University School of Medicine designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that IUSM may identify and resolve any conflicts of interest prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.
There are no relevant financial relationships with a commercial interest for anyone who was in control of the content of this activity, except:
- Susan Rawlins, NP has disclosed she is a consultant for Merck and Company, Inc. All conflicts have been resolved.
- Karen Tang, MD, MPH has disclosed she is on AbbVie Speaker’s Bureau.
*Indiana University School of Medicine (IUSM) defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
This activity is supported by an educational grant from AMAG Pharmaceuticals.
How to obtain continuing education credits after viewing the film
You must take Indiana University School of Medicine’s online test, online evaluation and download certificate: